JY-21

• Target:

  Epigenetic Reader Domain|||PROTACs

• Related Pathways:

  PROTAC|||Chromatin/Epigenetic

• Bioactivity:

  JY-21 is a BRD4 PROTAC degrader with a DC50 of 3.797 ?M, exhibiting potent anticancer activity against MDA-MB-231 cells.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C